Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2 (Randomised Controlled Phase II Clinical Trial)

NCT00514657 is registered in ClinicalTrials.gov with Kaken Pharmaceutical as lead sponsor.

NCT NCT00514657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00514657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2 (Randomised Controlled Phase II Clinical Trial)
Lead sponsor
Kaken Pharmaceutical
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2001
Completion date
February 29, 2004
Enrollment
91 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

periodontitis